The FDAnews Webinar Training Pass program offers year-round, unrestricted access to any of the hundreds of webinars listed below. These training programs feature thought leadership and best practices from top consultants, expert speakers and current and former FDA officials. New webinars are offered every month, along with access to the Webinar Training Pass archive.
BUY NOW Single-User 1-Year Unlimited Access $1,362
If you are already a Training Pass member, login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video, click the "Download Presentation" link.
Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Russ Titsch, Business Development Director at russ.titsch@wcgclinical.com or +1 703.538.7651 to receive a custom quote.
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
Recorded on: Aug. 6, 2019
Description: FDA regulatory and life sciences expert Bethany Hills-Grois shares best practices for understanding the current policies and proposed changes to the drug pricing and reimbursement landscape. She discusses:
- How drug pricing policies may impact labeling and promotional activity;
- Practical tips on product data development to align with drug pricing policies;
- The drug pricing and reimbursement framework, including the roles the FDA, CMS and private parties plan; and
- Drug pricing proposals being considered in Congress and those expected to pass before the November elections.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Bethany Hills-Grois, Partner, Morris & Foerster
Recorded on: Aug. 5, 2019
Description: Quality Assurance expert Susan Schniepp shares best practices on regulatory expectations for the prevention of data integrity issues, problem areas for data integrity and strategies for detecting potential data integrity issues in operations. She discusses:
- Recent FDA warning letters citing data integrity;
- Data integrity code of conduct;
- Problem areas where data integrity issues can arise; and
- Strategies for detecting data integrity issues in QC and laboratory, computer systems and manufacturing.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Susan J. Schniepp, Distinguished Fellow, Regulatory Compliances Associates, Inc.
Recorded on: Aug. 1, 2019
Description: Medical device expert Michael Gaba shares best practices to get your software as a medical device (SaMD) product to market faster with the Software Precertification Program. He discusses:
- How to streamline your pre-market review;
- How to leverage information and data obtained during pre-certification; and
- How to establish a more modern and tailored approach toward software integration.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Michael Gaba, Partner, Holland & Knight
Recorded on: July 30, 2019
Description: Legal experts Greg Levine and Kelly Combs shares best practices for understanding the expedited FDA approval programs for drugs and devices, what it takes to qualify and how to secure the benefits to make a difference in the bottom line. They discuss:
- How to explore eligibility criteria;
- How to get clarity on program features and benefits;
- How to discover designation criteria, including data generation requirements; and
- How to understand the designation review process.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Greg Levine, Partner and Co-Chair; Kelly Combs, Partner, Ropes & Gray LLP
Recorded on: July 26, 2019
Description: Compounding expert Karla Palmer shares industry expectations from, and accelerating enforcement of, the FDA’s 2018 Compounding Priorities Plan. She discusses:
- How sections 503A and 503B of the 2013 Drug Quality and Security Act affect compounding pharmacies and outsourcing facilities, and exactly what changes have been made in the draft and final guidances;
- How best to understand what enforcement actions the FDA has taken against compounders to-date and what the future may hold in regard to Warning Letters and 483s;
- What the FDA is looking for right now in compounding inspections; and
- The interplay between FDA and state regulation of outsourcing facilities and compounding pharmacies.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Karla Palmer, Director, Hyman Phelps & McNamara P.C.
Recorded on: July 25, 2019
Description: Cybersecurity expert Norma Krayem shares best practices for working with unchartered regulatory and liability risks and divulges new coping strategies to implement in the rapidly changing global regulatory landscape. She discusses:
- The cybersecurity-triggered changes in the interpretation of HIPPA;
- The DHS cybersecurity initiatives, including the Automated Information Sharing (AIS) program as they pertain to Homeland Security;
- Cybersecurity as an enterprise risk management issue affecting security, risk and privacy functions in device firms; and
- The Cybersecurity Information Sharing Act and the Protected Critical Infrastructure Information (PCII) as potential “safe harbors”.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Norma Krayem, Senior Policy Advisor, Holland & Knight LLP
Recorded on: July 18, 2019
Description: Industry expert Dan O’Leary shares how the latest regulations, standards and FDA guidance documents impact the validation of production processes of medical devices with animal tissue, and the implementation of compliant systems to protect patient and user health. He discusses:
- The elements of the FDA guidance document and how they fit into the U.S. regulatory system;
- The members of the ISO 22442 rule family and how they work together;
- The upcoming changes to the ISO 22442 rule family; and
- The approach to animal tissues in the EU-MDD and EU-MDR, and the factors for implementation.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Dan O’Leary, President, Ombu Enterprises, LLC
Recorded on: July 17, 2019
Description: Quality systems expert JP Zonnenberg and strategy expert Mike Jovanis share best practices on how to calculate anticipated benefits and savings and build a business case to justify quality transformations. They discuss:
- The framework for developing business cases;
- How to move from a cost to a value structure leveraging Quality 4.0;
- The recommendations on calculating TCO and key considerations; and
- Guidance on navigating complex organizations to get buy-in.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Jan Paul (JP) Zonnenberg, Partner, Pharmaceutical and Life Sciences Companies, PricewaterhouseCoopers; Mike Jovanis, Vice President, Vault Quality, Veeva Systems
Recorded on: June 26, 2019
Description: Industry expert David B. Russell shares proven ways to ensure that all the funds allowed in CTAs are collected during financial audits. He discusses:
- How to perform financial lookbacks on open studies and those in closeout;
- How to insert language into CTAs to ensure the study sponsor/CRO provides all the necessary documentation associated with payment;
- When to do a financial audit; and
- How best to handle budget amendments.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: David B. Russell, CRCP, Director, Site Strategy, PFS Clinical
Recorded on: June 26, 2019
Description: Quality Assurance expert Susan Schniepp shares best practices on the importance of an effective CAPA system, investigational techniques used in CAPA management and how CAPA can be used to drive continuous process improvements. She discusses:
- How to establish meaningful effectiveness checks;
- How to conduct world-class investigation process overviews to help comply with regulatory requirements;
- How to use discovery through closeout for every deviation from CAPA guidelines; and
- How to understand the nuances involved in lab OOS investigations.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Susan Schniepp, Distinguished Fellow, Regulatory Compliance Associates